Least Burdensome Draft Guidance Defers Issue Of Claims Substantiation
This article was originally published in The Gray Sheet
Executive Summary
Claims substantiation will be addressed in a future guidance separate from the Center for Devices and Radiological Health's draft guidance outlining "least burdensome" concepts and principles.
You may also be interested in...
CDRH “Least Burdensome” Guidance Promotes FDA Staff, Panelist Training
FDA plans to conduct training sessions to ensure that CDRH staffers and device advisory panel members apply "least burdensome" principles to their work, according to a final guidance posted on the CDRH website Sept. 30 and published in the Federal Register Oct. 4
CDRH “Least Burdensome” Guidance Promotes FDA Staff, Panelist Training
FDA plans to conduct training sessions to ensure that CDRH staffers and device advisory panel members apply "least burdensome" principles to their work, according to a final guidance posted on the CDRH website Sept. 30 and published in the Federal Register Oct. 4
AdvaMed Device Submissions Workshop In Brief
New 510(k) paradigm: Level 2 guidance document on 510(k)s is expected to be released by the end of the summer, Office of Device Evaluation Premarket Notification Staff Director Heather Rosecrans tells attendees at AdvaMed's device submissions workshop held June 6-7 in Rockville, Maryland. "We're right at the process of updating the new paradigm, and that's going to go through the GGP [good guidance practices] process. We're going to consider the truthful and accurate...statement in place of the declaration of conformity...with design controls, because there's no end and no beginning and there has been some confusion." Rosecrans highlighted one change for manufacturers submitting 510(k)s: "validation will have to be completed prior to going to market with your device"...